UBS rates A2M as Neutral
UBS has surveyed institutional investors and finds the market is bullish on a2 Milk, which signals that earnings upgrades and/or positive news on geographic or category expansion is needed for further outperformance.
Regulatory risk in China is now perceived as less important, which surprised the broker. UBS finds the near-term risk is weighted to the upside but to be more positive in the longer term needs greater confidence in the opportunity for market share in China as well as the US opportunity.
Neutral rating maintained. Target is NZ$14.00. (AU$13.40)
From FNArena broker call - free site access
UBS rates A2M as Neutral UBS has surveyed institutional...
Add A2M (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$4.81 |
Change
-0.050(1.03%) |
Mkt cap ! $3.808B | |||
| Open | High | Low | Value | Volume |
| $4.88 | $4.88 | $4.81 | $9.469M | 1.962M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 37717 | $4.81 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $4.83 | 10210 | 3 |
View Market Depth
| Last trade - 16.10pm 21/11/2024 (20 minute delay) ? |
| A2M (ASX) Chart |
